ProText
Wharton's jelly connective-tissue profile
HCPCS Q4246 reference
- Format
- Tissue material
- Access
- Documentation review
CONNECTIVE TISSUE PRODUCT PROFILE
Connective-tissue documentation for aesthetic review
Human umbilical cord / Wharton's jelly. Product identity and documentation for professional review.
CONNECTIVE TISSUE
Regenative Labs describes SecreText in its aesthetic tissue-support materials. Review the exact Wharton's jelly-derived product and its labeling; the manufacturer's application context is not evidence of FDA approval or clinical effectiveness.
PRODUCT CONFIGURATIONS
| Configuration | Item code | Details | Selection |
|---|---|---|---|
| 1 mL / 15 mg | ST100-32 | See product file | |
| 2 mL / 30 mg | ST200-32 | See product file |
DOCUMENTATION REQUEST
Item code ST100-32
Package presentation, not a patient dose or potency claim.
Request documentationInformation request only. No clinical use is authorized by this profile.
Dimensions and geometric areas describe product formats, not billable units. Use current source-issued labeling and the confirmed item code before ordering.
PRODUCT DOCUMENTATION
Specifications, instructions, and evidence belong with the exact product your team is reviewing.
REQUEST A PRODUCT FILE
Your selected configuration stays with your request.
Document availability and the responsible source are confirmed by the team. Selecting a document does not certify the product or establish approval.
Current labeling & instructions, Composition & specifications, Source & regulatory status
BEYOND THE SPECIFICATION
Review the exact source tissue, processing, package presentation, and current regulatory documentation. A product name or application context does not establish an authorized clinical use.
Materials & formatsThe standard SecreText range is listed at 15 mg/mL. SecreText Pro is a separate 25 mg/mL range in the manufacturer materials; its availability through Ventana has not been confirmed. Do not substitute the Pro range or infer equivalent use from the name.
Confirm the package basis with the source. A presentation quantity does not establish a patient dose or potency.
A FEW MORE DETAILS
CONTINUE EXPLORING